Skip to main content
Clinical Trials/TCTR20200422001
TCTR20200422001CompletedPhase 2

Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate

Faculty of Medicine Siriraj Hospital, Mahidol University0 sites45 target enrollmentStarted: April 21, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • Thai obese subjects, BMI ≥ 25 kg/m2 and age > 18 years, were recruited.

Exclusion Criteria

  • Subjects who were pregnant, lactating, menopause; had metabolic diseases (e.g. diabetes mellitus, hyper- or hypo-thyroidism, cushing syndrome), history of tea or caffeine hypersensitivity, a medical condition that causes weight gain known as secondary obesity (e.g. endocrine disorders, hypothalamic disorders, and some congenital conditions); used any forms of weight-reducing medications or any kinds of medications; and performed regular exercise (at least 30 min/session, 3 times per week48) were excluded.

Investigators

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University

Similar Trials